|
|
SPOT ON
|
|
How meaningful are studies that are stopped early?
|
|
|
THERAPIES FROM A CRITICAL VIEW POINT
|
|
Fenofibrate (e.g. LIPANTHYL) for type 2 diabetes?
Beta-blockers: only second line in hypertension?
Clopidogrel (ISCOVER, PLAVIX) and metoprolol (e.g. BELOC) in acute myocardial infarction
|
|
IDEAL-study: high-dose atorvastatin (SORTIS) not better than simvastatin (e.g. ZOCOR)
|
|
|
a-t READERS' QUESTIONS AND COMMENTS
|
|
Is venlafaxine (TREVILOR) superior to other antidepressants?
Mistletoe (e.g. ISCADOR) and quality of life in cancer
|
|
|
IN BRIEF
|
|
Quality check: metoclopramide (e.g. PASPERTIN)
German "Sportbund": cachet for dietary supplements?
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Depression with angiotensin II receptor antagonists like olmesartan (OLMETEC, VOTUM)
|
|
|
SIDE EFFECTS
|
|
Oseltamivir (TAMIFLU): dangerous abnormal behaviour and suicides in children?
EVRA transdermal contraceptive: thromboembolism due to high estrogen levels?
|
|